top of page
RESTART tICrH - A Randomised Trial of Timing to Restart Direct Oral Anticoagulants after Traumatic Intracranial Haemorrhage
RESTART tICrH is a multi-site, randomised controlled study. The overall aim of this study is to compare the clinical effectiveness of restarting/starting DOAC earlier (1 week) versus later (4 weeks) following tICrH.
The trial is funded by the National Institute for Health Research's Health Technology Assessment Programme (NIHR HTA) and is sponsored by The Walton Centre NHS Foundation Trust. The day-to-day running of the trial, monitoring and analysis is being coordinated by a team at the Liverpool Clinical Trials Centre (LCTC).
For further details please visit the study site:
bottom of page